United States Non-biodegradable Polymer-based Drug Eluting Stent Market Report 2017

January 2017 | 99 pages | ID: U5EFF2292E5EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Non-biodegradable Polymer-based Drug Eluting Stent

Revenue, means the sales value of Non-biodegradable Polymer-based Drug Eluting Stent

This report studies sales (consumption) of Non-biodegradable Polymer-based Drug Eluting Stent in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Boston Scientific Corporation
• Medtronic
• Lepu Medical
• Stentsys

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Micro porous Surface
• Slotted Tubular Surface

Split by applications, this report focuses on sales, market share and growth rate of Non-biodegradable Polymer-based Drug Eluting Stent in each application, can be divided into

• Coronary Artery Disease
• Peripheral Artery Disease

Contents

United States Non-biodegradable Polymer-based Drug Eluting Stent Market Report 2017

1 NON-BIODEGRADABLE POLYMER-BASED DRUG ELUTING STENT OVERVIEW

1.1 Product Overview and Scope of Non-biodegradable Polymer-based Drug Eluting Stent
1.2 Classification of Non-biodegradable Polymer-based Drug Eluting Stent
  1.2.1 Micro porous Surface
  1.2.2 Slotted Tubular Surface
1.3 Application of Non-biodegradable Polymer-based Drug Eluting Stent
  1.3.1 Coronary Artery Disease
  1.3.2 Peripheral Artery Disease
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Non-biodegradable Polymer-based Drug Eluting Stent (2011-2021)
  1.4.1 United States Non-biodegradable Polymer-based Drug Eluting Stent Sales and Growth Rate (2011-2021)
  1.4.2 United States Non-biodegradable Polymer-based Drug Eluting Stent Revenue and Growth Rate (2011-2021)

2 UNITED STATES NON-BIODEGRADABLE POLYMER-BASED DRUG ELUTING STENT COMPETITION BY MANUFACTURERS

2.1 United States Non-biodegradable Polymer-based Drug Eluting Stent Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Non-biodegradable Polymer-based Drug Eluting Stent Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Non-biodegradable Polymer-based Drug Eluting Stent Average Price by Manufactures (2015 and 2016)
2.4 Non-biodegradable Polymer-based Drug Eluting Stent Market Competitive Situation and Trends
  2.4.1 Non-biodegradable Polymer-based Drug Eluting Stent Market Concentration Rate
  2.4.2 Non-biodegradable Polymer-based Drug Eluting Stent Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES NON-BIODEGRADABLE POLYMER-BASED DRUG ELUTING STENT SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Non-biodegradable Polymer-based Drug Eluting Stent Sales and Market Share by States (2011-2016)
3.2 United States Non-biodegradable Polymer-based Drug Eluting Stent Revenue and Market Share by States (2011-2016)
3.3 United States Non-biodegradable Polymer-based Drug Eluting Stent Price by States (2011-2016)

4 UNITED STATES NON-BIODEGRADABLE POLYMER-BASED DRUG ELUTING STENT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Non-biodegradable Polymer-based Drug Eluting Stent Sales and Market Share by Type (2011-2016)
4.2 United States Non-biodegradable Polymer-based Drug Eluting Stent Revenue and Market Share by Type (2011-2016)
4.3 United States Non-biodegradable Polymer-based Drug Eluting Stent Price by Type (2011-2016)
4.4 United States Non-biodegradable Polymer-based Drug Eluting Stent Sales Growth Rate by Type (2011-2016)

5 UNITED STATES NON-BIODEGRADABLE POLYMER-BASED DRUG ELUTING STENT SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Non-biodegradable Polymer-based Drug Eluting Stent Sales and Market Share by Application (2011-2016)
5.2 United States Non-biodegradable Polymer-based Drug Eluting Stent Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES NON-BIODEGRADABLE POLYMER-BASED DRUG ELUTING STENT MANUFACTURERS PROFILES/ANALYSIS

6.1 Boston Scientific Corporation
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Non-biodegradable Polymer-based Drug Eluting Stent Product Type, Application and Specification
    6.1.2.1 Micro porous Surface
    6.1.2.2 Slotted Tubular Surface
  6.1.3 Boston Scientific Corporation Non-biodegradable Polymer-based Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Medtronic
  6.2.2 Non-biodegradable Polymer-based Drug Eluting Stent Product Type, Application and Specification
    6.2.2.1 Micro porous Surface
    6.2.2.2 Slotted Tubular Surface
  6.2.3 Medtronic Non-biodegradable Polymer-based Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Lepu Medical
  6.3.2 Non-biodegradable Polymer-based Drug Eluting Stent Product Type, Application and Specification
    6.3.2.1 Micro porous Surface
    6.3.2.2 Slotted Tubular Surface
  6.3.3 Lepu Medical Non-biodegradable Polymer-based Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Stentsys
  6.4.2 Non-biodegradable Polymer-based Drug Eluting Stent Product Type, Application and Specification
    6.4.2.1 Micro porous Surface
    6.4.2.2 Slotted Tubular Surface
  6.4.3 Stentsys Non-biodegradable Polymer-based Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview

7 NON-BIODEGRADABLE POLYMER-BASED DRUG ELUTING STENT MANUFACTURING COST ANALYSIS

7.1 Non-biodegradable Polymer-based Drug Eluting Stent Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Non-biodegradable Polymer-based Drug Eluting Stent

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Non-biodegradable Polymer-based Drug Eluting Stent Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Non-biodegradable Polymer-based Drug Eluting Stent Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES NON-BIODEGRADABLE POLYMER-BASED DRUG ELUTING STENT MARKET FORECAST (2016-2021)

11.1 United States Non-biodegradable Polymer-based Drug Eluting Stent Sales, Revenue Forecast (2016-2021)
11.2 United States Non-biodegradable Polymer-based Drug Eluting Stent Sales Forecast by Type (2016-2021)
11.3 United States Non-biodegradable Polymer-based Drug Eluting Stent Sales Forecast by Application (2016-2021)
11.4 Non-biodegradable Polymer-based Drug Eluting Stent Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Non-biodegradable Polymer-based Drug Eluting Stent
Table Classification of Non-biodegradable Polymer-based Drug Eluting Stent
Figure United States Sales Market Share of Non-biodegradable Polymer-based Drug Eluting Stent by Type in 2015
Figure Micro porous Surface Picture
Figure Slotted Tubular Surface Picture
Table Application of Non-biodegradable Polymer-based Drug Eluting Stent
Figure United States Sales Market Share of Non-biodegradable Polymer-based Drug Eluting Stent by Application in 2015
Figure Coronary Artery Disease Examples
Figure Peripheral Artery Disease Examples
Figure United States Non-biodegradable Polymer-based Drug Eluting Stent Sales and Growth Rate (2011-2021)
Figure United States Non-biodegradable Polymer-based Drug Eluting Stent Revenue and Growth Rate (2011-2021)
Table United States Non-biodegradable Polymer-based Drug Eluting Stent Sales of Key Manufacturers (2015 and 2016)
Table United States Non-biodegradable Polymer-based Drug Eluting Stent Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Non-biodegradable Polymer-based Drug Eluting Stent Sales Share by Manufacturers
Figure 2016 Non-biodegradable Polymer-based Drug Eluting Stent Sales Share by Manufacturers
Table United States Non-biodegradable Polymer-based Drug Eluting Stent Revenue by Manufacturers (2015 and 2016)
Table United States Non-biodegradable Polymer-based Drug Eluting Stent Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Non-biodegradable Polymer-based Drug Eluting Stent Revenue Share by Manufacturers
Table 2016 United States Non-biodegradable Polymer-based Drug Eluting Stent Revenue Share by Manufacturers
Table United States Market Non-biodegradable Polymer-based Drug Eluting Stent Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Non-biodegradable Polymer-based Drug Eluting Stent Average Price of Key Manufacturers in 2015
Figure Non-biodegradable Polymer-based Drug Eluting Stent Market Share of Top 3 Manufacturers
Figure Non-biodegradable Polymer-based Drug Eluting Stent Market Share of Top 5 Manufacturers
Table United States Non-biodegradable Polymer-based Drug Eluting Stent Sales by States (2011-2016)
Table United States Non-biodegradable Polymer-based Drug Eluting Stent Sales Share by States (2011-2016)
Figure United States Non-biodegradable Polymer-based Drug Eluting Stent Sales Market Share by States in 2015
Table United States Non-biodegradable Polymer-based Drug Eluting Stent Revenue and Market Share by States (2011-2016)
Table United States Non-biodegradable Polymer-based Drug Eluting Stent Revenue Share by States (2011-2016)
Figure Revenue Market Share of Non-biodegradable Polymer-based Drug Eluting Stent by States (2011-2016)
Table United States Non-biodegradable Polymer-based Drug Eluting Stent Price by States (2011-2016)
Table United States Non-biodegradable Polymer-based Drug Eluting Stent Sales by Type (2011-2016)
Table United States Non-biodegradable Polymer-based Drug Eluting Stent Sales Share by Type (2011-2016)
Figure United States Non-biodegradable Polymer-based Drug Eluting Stent Sales Market Share by Type in 2015
Table United States Non-biodegradable Polymer-based Drug Eluting Stent Revenue and Market Share by Type (2011-2016)
Table United States Non-biodegradable Polymer-based Drug Eluting Stent Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Non-biodegradable Polymer-based Drug Eluting Stent by Type (2011-2016)
Table United States Non-biodegradable Polymer-based Drug Eluting Stent Price by Type (2011-2016)
Figure United States Non-biodegradable Polymer-based Drug Eluting Stent Sales Growth Rate by Type (2011-2016)
Table United States Non-biodegradable Polymer-based Drug Eluting Stent Sales by Application (2011-2016)
Table United States Non-biodegradable Polymer-based Drug Eluting Stent Sales Market Share by Application (2011-2016)
Figure United States Non-biodegradable Polymer-based Drug Eluting Stent Sales Market Share by Application in 2015
Table United States Non-biodegradable Polymer-based Drug Eluting Stent Sales Growth Rate by Application (2011-2016)
Figure United States Non-biodegradable Polymer-based Drug Eluting Stent Sales Growth Rate by Application (2011-2016)
Table Boston Scientific Corporation Basic Information List
Table Boston Scientific Corporation Non-biodegradable Polymer-based Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Boston Scientific Corporation Non-biodegradable Polymer-based Drug Eluting Stent Sales Market Share (2011-2016)
Table Medtronic Basic Information List
Table Medtronic Non-biodegradable Polymer-based Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2011-2016)
Table Medtronic Non-biodegradable Polymer-based Drug Eluting Stent Sales Market Share (2011-2016)
Table Lepu Medical Basic Information List
Table Lepu Medical Non-biodegradable Polymer-based Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lepu Medical Non-biodegradable Polymer-based Drug Eluting Stent Sales Market Share (2011-2016)
Table Stentsys Basic Information List
Table Stentsys Non-biodegradable Polymer-based Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2011-2016)
Table Stentsys Non-biodegradable Polymer-based Drug Eluting Stent Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-biodegradable Polymer-based Drug Eluting Stent
Figure Manufacturing Process Analysis of Non-biodegradable Polymer-based Drug Eluting Stent
Figure Non-biodegradable Polymer-based Drug Eluting Stent Industrial Chain Analysis
Table Raw Materials Sources of Non-biodegradable Polymer-based Drug Eluting Stent Major Manufacturers in 2015
Table Major Buyers of Non-biodegradable Polymer-based Drug Eluting Stent
Table Distributors/Traders List
Figure United States Non-biodegradable Polymer-based Drug Eluting Stent Production and Growth Rate Forecast (2016-2021)
Figure United States Non-biodegradable Polymer-based Drug Eluting Stent Revenue and Growth Rate Forecast (2016-2021)
Table United States Non-biodegradable Polymer-based Drug Eluting Stent Production Forecast by Type (2016-2021)
Table United States Non-biodegradable Polymer-based Drug Eluting Stent Consumption Forecast by Application (2016-2021)
Table United States Non-biodegradable Polymer-based Drug Eluting Stent Sales Forecast by States (2016-2021)
Table United States Non-biodegradable Polymer-based Drug Eluting Stent Sales Share Forecast by States (2016-2021)